A61K 38/24
Follicle-stimulating hormone [fsh]
Official title: Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
A61K38/24 (Follicle-stimulating hormone [fsh]) appears on 294 US grants and 481 published applications in this corpus.
Search patents in A61K- Granted patents
- 294
- Published applications
- 481
- Assignees
- 247
- Inventors
- 723
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 7 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 6 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 5 | 2 |
| 2002 | 4 | 9 |
| 2003 | 4 | 9 |
| 2004 | 4 | 27 |
| 2005 | 8 | 22 |
| 2006 | 10 | 31 |
| 2007 | 6 | 22 |
| 2008 | 9 | 21 |
| 2009 | 6 | 14 |
| 2010 | 18 | 14 |
| 2011 | 12 | 21 |
| 2012 | 12 | 21 |
| 2013 | 10 | 24 |
| 2014 | 13 | 18 |
| 2015 | 18 | 31 |
| 2016 | 14 | 19 |
| 2017 | 5 | 26 |
| 2018 | 18 | 17 |
| 2019 | 10 | 20 |
| 2020 | 11 | 13 |
| 2021 | 11 | 16 |
| 2022 | 10 | 19 |
| 2023 | 6 | 14 |
| 2024 | 6 | 15 |
| 2025 | 7 | 25 |
| 2026 | 7 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition comprising HP-hMG for use in treating infertility4 Aug 2026US 12,697,372 B2Ferring B. V.
- Batch management method for improving farrowing rate or number of piglets born alive in swine14 Jul 2026US 12,678,488 B2China Agricultural University
- Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals23 Jun 2026US 12,661,321 B2Therio, LLC
- Recombinant FSH composition for controlled ovarian stimulation16 Jun 2026US 12,653,864 B2Ferring B. V.
- Ligands of the fsh hormone receptor in the diagnosis and treatment of tumors2 Jun 2026US 12,642,841 B2Oncogreen Therapeutics SA
- Injectable gel composition17 Sep 2026US 2026/0272823 A1Maman Biomedical Inc.
- Dissolvable microneedle patch for large molecule therapeutic delivery17 Sep 2026US 2026/0273253 A1Maman Biomedical Inc.
- Uses of fgf21 fusion proteins3 Sep 2026US 2026/0256885 A1Ampsource Biopharma Shanghai Inc.
- Methods for Improving Leptin Sensitivity for the Treatment of Obesity and Diabetes3 Sep 2026US 2026/0256888 A1University of Massachusetts
- Xten conjugate compositions and methods of making same16 Jul 2026US 2026/0199434 A1Amunix Pharmaceuticals, Inc.
Most cited
By later US patents
- Submicron emulsions for delivery of peptides153US 5,514,670 APharmos Corporation · 1996
- Drug administration128US 4,746,508 ABeth Israel Hospital Assn. · 1988
- Preservative-free follicle stimulating hormone solution delivery device113US 8,361,025 B2Carebay Holding Ltd. · 2013
- Use of Zeranol to modulate reproductive cycles106US 6,087,352 A2000
- Stable topical drug delivery compositions100US 7,182,956 B22007